Search

Search results

Woman asking question using microphone

Get involved

Our community are the reason we are able to continue supporting those with inherited sight-loss conditions through research and practical support.

Genetic testing: an essential topic for discussion with the IRD community

As Luxturna reaches the clinic and other gene-specific therapies for inherited retinal disease get closer to the end of the development pipeline, it is becoming ever more important that affected families can access a genetic diagnosis, potentially opening up choices around treatment and clinical trial participation.